Adient plc director Carlin Peter sold 7,843 shares at $19.25 per share on Sep 2, 2026, leaving him with 38,835 shares. The transaction gives investors a reported update on the director’s remaining ownership in Adient, while the disclosed sale price and date identify the transaction’s terms.
Key Highlights
- Carlin Peter’s reported Adient holding stood at 38,835 shares after the transaction.
- The transaction was recorded under code S.
- Carlin Peter sold 7,843 Adient shares.
Carlin Peter, a director of Adient plc (NYSE: ADNT), sold 7,843 shares. The transaction was dated Sep 2, 2026.
Director’s Adient Holding After the Sale
Peter’s reported ownership after the transaction was 38,835 shares. The sale price was $19.25 per share. The transaction was recorded under code S. Peter is identified in the transaction details as a director of Adient plc. The disclosed figures cover both the share sale and Peter’s reported position after the transaction. Adient’s transaction details associate the 38,835-share balance with Peter after the sale.
FAQs
Q: How many Adient shares did Carlin Peter sell?
A: Carlin Peter sold 7,843 Adient shares. The shares were sold at $19.25 per share in the disclosed director transaction. The filing identifies Carlin Peter as a director of Adient plc.
Q: How many Adient shares did Carlin Peter own after the sale?
A: Carlin Peter’s reported ownership after the transaction was 38,835 Adient shares. The balance reflects his position following the sale. The filing identifies this as his post-transaction reported position.
Q: When did the Adient director share sale occur?
A: The Adient director transaction was dated Sep 2, 2026. It was recorded under transaction code S and involved 7,843 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.